Literature DB >> 31582093

Perioperative blood pressure monitoring.

Joshua K Roach1, Robert H Thiele2.   

Abstract

Arterial blood pressure monitoring is a major part of the decision-making process for every anesthetic. It is important to recognize the advantages, disadvantages, and limitations of available measurement modalities as well as have some understanding of the engineering principles on which these measurements are based. Oscillometry is by far the most common modality used but is limited by its intermittent nature and inaccuracy during hypotension and hypertension. Arterial catheterization is the gold standard for measuring blood pressure but is an invasive procedure that is expensive and not without risk of harm to the patient. Volume clamp and tonometric technologies are relatively new and allow for continuous noninvasive monitoring of the blood arterial waveform, but their accuracy when compared with oscillometry is not well described, and they have not been widely incorporated into standard practice. Additional research is needed to determine whether continuous noninvasive blood pressure monitors can improve outcomes.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Windkessel; blood pressure; flush test; tonometry; volume clamp

Mesh:

Year:  2019        PMID: 31582093     DOI: 10.1016/j.bpa.2019.05.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  2 in total

1.  Clinical Validation of a Soft Wireless Continuous Blood Pressure Sensor During Surgery.

Authors:  En-Fan Chou; Shin Yu Celia Cheung; Hailey Christine Maxwell; Nicholas Pham; Michelle Khine; Joseph Rinehart
Journal:  Front Digit Health       Date:  2021-07-22

2.  Distal radial artery as an alternative approach to forearm radial artery for perioperative blood pressure monitoring: a randomized, controlled, noninferiority trial.

Authors:  Jingwei Xiong; Kangli Hui; Miaomiao Xu; Jiejie Zhou; Jie Zhang; Manlin Duan
Journal:  BMC Anesthesiol       Date:  2022-03-09       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.